trending Market Intelligence /marketintelligence/en/news-insights/trending/mmgjxnsway2zx03eh4qmiw2 content esgSubNav
In This List

OptimizeRx implements reverse stock split to qualify for Nasdaq listing

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global M&A By the Numbers: Q2 2021

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times


OptimizeRx implements reverse stock split to qualify for Nasdaq listing

OptimizeRx Corp. implemented a 1-for-3 reverse split of its common stock to qualify for listing on the Nasdaq Capital Market.

The reverse split reduced OptimizeRx's issued and outstanding common shares to 11,546,000 from 34,636,811.

Following the split, Nasdaq will review the company's listing application. OptimizeRx said there is no assurance the exchange will approve its application.

The company believes trading on Nasdaq will help increase its appeal to retail and institutional investors, expanding its shareholder base.

Rochester, Mich.-based OptimizeRx is an OTCQB-listed provider of digital health messaging for the pharmaceutical industry.